SLC5A2 and diabetic cardiomyopathy: Furthermore, hyperglycemic over-stress induces upregulation of Sodium-glucose cotransporter-2 (SGLT2) expression in cardiomyocytes [11] and using SGLT2 inhibitors can improve cardiac function in diabetic cardiomyopathy by reducing JunD expression [12].